ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p115.xmlPredictors and Temporal Trends of Adjuvant Aromatase Inhibitor Use in Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p115.pdf2026-04-18Predictors and Temporal Trends of Adjuvant Aromatase Inhibitor Use in Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p109.xmlPersonalized Medicine and Breast Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p109.pdf2026-04-18Personalized Medicine and Breast Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p122.xmlBreast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p122.pdf2026-04-18Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p203.xmlPharmacogenetics of Tamoxifen: Who Should Undergo CYP2D6 Genetic Testing?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p203.pdf2026-04-18Pharmacogenetics of Tamoxifen: Who Should Undergo CYP2D6 Genetic Testing?https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p215.xmlAccelerated Partial Breast Irradiation: Where Do We Stand?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p215.pdf2026-04-18Accelerated Partial Breast Irradiation: Where Do We Stand?https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p193.xmlIndications for Breast MRI in the Patient with Newly Diagnosed Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p193.pdf2026-04-18Indications for Breast MRI in the Patient with Newly Diagnosed Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p226.xmlGeriatric Assessment in Older Patients with Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/7/2/article-p226.pdf2026-04-18Geriatric Assessment in Older Patients with Breast Cancer